Transforming Ideas into Impactful Solutions

We fund companies advancing MUSC Innovations.

Accelerating innovative solutions from our backyard to advance the future of healthcare.

image1

1824 Health Ventures is an early-stage venture fund dedicated to investing in startups associated with the Medical University of South Carolina (MUSC). Our mission is to provide seed capital that demonstrates MUSC’s commitment to fostering a robust innovation ecosystem.

image2

1824 Health Ventures bridges the gap between research and commercialization, accelerating the journey from discovery to impact. Our investment strategy focuses on high-potential startups emerging from MUSC’s ecosystem, including those leveraging intellectual property developed within the university.

Investment Strategy

We’re more than capital—we’re committed collaborators in health innovation.
image4
grpahics

Internal Innovation Catalyst

Exclusively funding high-potential startups using technology from MUSC, acting as a dedicated venture arm.

grpahics
image5

Future Of Healthcare Focus

Strategically investing in groundbreaking technologies and solutions that promise to redefine and advance the landscape of healthcare delivery and outcomes.

image6

MUSC Ecosystem Advantage

Leveraging the deep clinical, research and entrepreneurial expertise within MUSC to identify, nurture and accelerate promising ventures.

Rooted in MUSC, connected to the world

Partnering with pioneers. Building the future of care.

We invest in early-stage startups at the forefront of digital health, medical devices, and therapeutics—transforming research into scalable real-world solutions.

Meet Us - Visionaries

Behind Health Ventures is a dynamic team of healthcare leaders, investors strategists committed to fueling ideas generated by the Medical University of South Carolina.

Rooted in MUSC, connected to the world

Our Portfolio

We invest in early-stage companies that are redefining what’s possible in health and medicine.

Leukogene Therapeutics, Inc.

Leukogene Therapeutics, Inc. is a cancer biotherapeutics company delivering innovative immunotherapies for patients living with cancer.
image16
image14

Leukogene Therapeutics, Inc.

Leukogene Therapeutics, Inc. is a cancer biotherapeutics company delivering innovative immunotherapies for patients living with cancer.
image17
image14

Leukogene Therapeutics, Inc.

Leukogene Therapeutics, Inc. is a cancer biotherapeutics company delivering innovative immunotherapies for patients living with cancer.
x  Powerful Protection for WordPress, from Shield Security
This Site Is Protected By
WebPro360 ShieldPRO